2026 Q1 Portfolio Activity
In 2026 Q1, FCPM III SERVICES B.V. maintained a portfolio of 11 distinct positions. The most significant new addition was DAMORA THERAPEUTICS INC, now representing 8.75% of the total fund value. They heavily accumulated shares in VOR BIOPHARMA INC, increasing the position by 13.8%. Conversely, FCPM III SERVICES B.V. completely exited their position in RAPT THERAPEUTICS INC.
Position History
hover any row below to update
Loading…
Total Positions
11
Quarter
2026 Q1
Top Holding
NAMS (40.8%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-11 of 11
FCPM III SERVICES B.V. Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 40.77% | 42.30% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
9,198,900 | $294,456,789 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 11.66% | 14.01% |
#2
Prev: #2
|
6.0 |
—
|
-818,460 | -15.0% |
P
S
|
4,644,386 | $84,202,718 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 10.17% | 6.20% |
#3
3
Prev: #6
|
7.0 |
—
|
500,000 | 13.8% |
P
S
|
4,117,354 | $73,453,595 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ENGN
ENGENE HOLDINGS...
|
Healthcare | 9.08% | 11.40% |
#4
1
Prev: #3
|
5.1 |
—
|
no change | no change |
P
S
|
9,632,561 | $65,597,740 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 9.08% | 7.43% |
#5
Prev: #5
|
5.1 |
—
|
no change | no change |
P
S
|
3,226,400 | $65,592,712 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
GLTO
DAMORA THERAPEU...
|
Healthcare | 8.75% | — |
#6
Prev: #—
|
7.0 |
—
|
2,441,000 | — |
NEW
|
2,441,000 | $63,221,900 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 4.27% | 2.61% |
#7
2
Prev: #9
|
2.7 |
—
|
no change | no change |
P
S
|
1,677,852 | $30,822,141 | — | 13F Filing | 2026-03-31 | 2026-05-15 | ||
|
REPL
REPLIMUNE GROUP...
|
Healthcare | 2.97% | 3.58% |
#8
1
Prev: #7
|
2.2 |
—
|
no change | no change |
P
S
|
2,808,368 | $21,484,015 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
BCYC
BICYCLE THERAPE...
|
Healthcare | 2.23% | 3.22% |
#9
1
Prev: #8
|
1.9 |
—
|
no change | no change |
P
S
|
3,468,430 | $16,093,515 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
ENGNW
ENGENE HOLDINGS...
|
Unknown | 1.01% | 1.12% |
#10
Prev: #10
|
1.4 |
—
|
no change | no change |
P
S
|
2,878,148 | $7,281,714 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-15 | |||
|
RAPT
RAPT THERAPEUTI...
|
Healthcare | 0.00% | 8.14% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-1,833,333 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-15 |
Showing 1-11 of 11 holdings